Charles River Laboratories CRL Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's investing cash flow?
- Charles River Laboratories (CRL) reported investing cash flow of -$407.85M in Q1 2026.
- How has Charles River Laboratories's investing cash flow changed year-over-year?
- Charles River Laboratories's investing cash flow decreased by 796.8% year-over-year, from -$45.48M to -$407.85M.
- What is the long-term trend for Charles River Laboratories's investing cash flow?
- Over 4 years (2021 to 2025), Charles River Laboratories's investing cash flow has grown at a -38.3% compound annual growth rate (CAGR), from -$1.45B to -$209.32M.
- What does investing cash flow mean?
- The net cash impact of buying and selling long-term assets and investments.
- How do you interpret investing cash flow?
- Negative values typically indicate aggressive investment in growth, while positive values may signal asset liquidation or a lack of capital deployment.
- How does investing cash flow compare across companies?
- Typically negative for growing companies; positive for companies in harvest or liquidation phases.